Pharma

A child using a pre-commercial version of Akili's product.
Full results of EndeavorRx adjunct trial show longer benefits with or without stimulant therapy
By Dave Muoio | 04:07 pm | March 29, 2021
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
insitro's AI drug discovery platform pulls another $400M from investors
By Dave Muoio | 01:13 pm | March 15, 2021
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.